Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-17T17:15:47.387Z Has data issue: false hasContentIssue false

Urinary Catecholamine Metabolite and Tribulin Output During Lactate Infusion

Published online by Cambridge University Press:  02 January 2018

Angela Clow
Affiliation:
Bernhard Baron Memorial Research Laboratories, Queen Charlotte's Hospital
Vivette Glover
Affiliation:
Bernhard Baron Memorial Research Laboratories, Queen Charlotte's Hospital
M. W. Weg
Affiliation:
Bernhard Baron Memorial Research Laboratories, Queen Charlotte's Hospital
P. L. Walker
Affiliation:
Bernhard Baron Memorial Research Laboratories, Queen Charlotte's Hospital Department of Biochemistry, Pinderfields General Hospital, Wakefield
D. V. Sheehan
Affiliation:
Massachusetts General Hospital; now at University South Florida Psychiatry Center, Tampa
D. B. Carr
Affiliation:
Endocrine Unit, Massachusetts General Hospital, Boston
M. Sandler*
Affiliation:
Bernhard Baron Memorial Research Laboratories, Queen Charlotte's Hospital
*
Queen Charlotte's Hospital, Goldhawk Road, London W6 0XG

Abstract

Urinary output of homovanillic acid and 4-hydroxy-3-methoxymandelic acid was decreased both in patients with panic attacks and in normal controls during lactate infusion, whereas that of tribulin (an endogenous monoamine oxidase inhibitor and benzodiazepine receptor binding inhibitor) was increased. There was no change in urinary excretion of any of these compounds during saline infusion. These findings provide further evidence of a link between tribulin output and stress and anxiety in man and point to its possible in vivo action as a monoamine oxidase inhibitor.

Type
Papers
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd cdn). (DSM-III). Washington DC: American Psychiatric Association.Google Scholar
Appelby, I. L., Klein, D. F., Sachar, E. J. & Levitt, H. (1981) Biochemical indices of lactate induced panic. In Anxiety: New Research, Changing Concepts (eds D. F. Klein, J. G. Rabkin). New York: Raven Press.Google Scholar
Armando, I., Barontini, M., Levin, G., Simsolo, R., Glover, V. & Sandler, M. (1984) Exercise increases endogenous urinary monoamine oxidase-benzodiazepine receptor ligand inhibitory activity in normal children. Journal of the Autonomic Nervous System, 11, 95100.Google Scholar
Armando, I., Barontini, M., Levin, G., Simsolo, R., Glover, V., Sandler, M., Glover, V. & Sandler, M. (1986) Distribution of endogenous benzodiazepine receptor ligand-monoamine oxidase inhibitory activity (tribulin) in tissues. Life Sciences, 38, 20632067.CrossRefGoogle ScholarPubMed
Bhattacharya, S. K., Glover, V., Sandler, M., Clow, A., Topham, A., Bernadt, M. & Murray, R. (1982) Raised endogenous monoamine oxidase inhibitor output in postwithdrawal alcoholics: effects of L-dopa and ethanol. Biological Psychiatry, 17, 829836.Google Scholar
Carr, D. B., Sheehan, D. V., Surman, O. S., Coleman, J. H., Greenblatt, D. J., Heninoer, G. R., Jones, K. H., Levine, P. H. & Watkins, W. D. (1986) Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy. American Journal of Psychiatry, 143, 483494.Google Scholar
Clow, A., Glover, V., Armando, I. & Sandler, M. (1983) New endogenous benzodiazepine receptor ligand in human urine: identity with endogenous monoamine oxidase inhibitor? Life Sciences, 33, 735741.Google Scholar
Dorow, R., Horowski, R., Paschelke, G. & Amin, M. (1983) Severe anxiety induced by FG 7142, a β-carboline ligand for benzodiazepine receptors. The Lancet, ii, 9899.Google Scholar
Elsworth, J. D., Glover, V. & Sandler, M. (1984) Feedback inhibition of monoamine oxidase? Journal of Pharmacy and Pharmacology, 36, 11W.Google Scholar
Elsworth, J. D., Glover, V., Sandler, M., Dewar, D., Glover, V., Goodwin, B. L., Clow, A. & Sandler, M. (1986) Purification and characterization of tribulin, an endogenous inhibitor of monoamine oxidase and of benzodiazepine receptor binding. Journal of Neural Transmission, 67, 4556.Google Scholar
Fellows, L., Riederer, P. & Sandler, M. (1975) A rapid assay of 4-hydroxy-3-methoxyphenylglycol in urine. Clinica Chimica Acta, 59, 255257.Google Scholar
Glover, V., Reveley, M. A. & Sandler, M. (1980) Monoamine oxidase inhibitor in human urine. Biochemical Pharmacology, 29, 467470.Google Scholar
Glover, V., Reveley, M. A., Sandler, M., Bhattacharya, S. K., Sandler, M. & File, S. E. (1981) Benzodiazepines reduce stress-augmented increase in rat urine monoamine oxidase inhibitor. Nature (London), 292, 347349.Google Scholar
Hamlin, C. I., Lydiard, R. B., Martin, D., Dackis, C. A., Pottash, A. C., Sweeney, D. & Gold, M. S. (1983) Urinary excretion of noradrenaline metabolite decreased in panic disorder. The Lancet, ii, 740741.Google Scholar
Insel, T. R., Ninan, P. T., Aloi, J., Jimerson, D. C., Skolnick, P. & Paul, S. M. (1984) A benzodiazepine receptor-mediated model of anxiety. Archives of General Psychiatry, 41, 741750.Google Scholar
Klein, D. F. (1964) Delineation of two drug responsive anxiety syndromes. Psychopharmacologia, 5, 397408.Google Scholar
Klein, D. F. (1967) Importance of psychiatric diagnosis in prediction of clinical drug effects. Archives of General Psychiatry, 16, 118126.Google Scholar
Liebowitz, M. R., Fyer, A. J., Gorman, J. M., Dillon, D., Appelby, I. L., Levy, G., Anderson, S., Levitt, M., Palij, M., Davies, S. O. & Klein, D. F. (1984) Lactate provocation of panic attacks. Archives of General Psychiatry, 41, 764770.Google Scholar
Liebowitz, M. R., Fyer, A. J., Gorman, J. M., Dillon, D., Appelby, I. L., Levy, G., Anderson, S., Levitt, M., Palij, M., Davies, S. O., Klein, D. F., Gorman, J. M., Fyer, A., Dillon, D., Levfit, M. & Klein, D. F. (1986) Possible mechanisms for lactate's induction of panic. American Journal of Psychiatry, 143, 495502.Google Scholar
Petursson, H., Bhattacharya, S. K., Glover, V., Sandler, M. Sandler, M. H. (1982) Urinary monoamine oxidase inhibitor and benzodiazepine withdrawal. British Journal of Psychiatry, 140, 710.Google Scholar
Sheehan, D. V., Ballenger, J. & Jacobson, G. (1980) Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Archives of General Psychiatry, 31, 5159.Google Scholar
Sheehan, D. V., Ballenger, J., Jacobson, G., Coleman, J. H., Greenblatt, D. J., Jones, K. J., Levine, P. H., Orsulak, P. J., Peterson, M., Schildkraut, J. J., Uzogara, E. & Watkins, D. (1984) Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. Journal of Clinical Psychopharmacology, 4, 6675.Google Scholar
Sheehan, D. V., Ballenger, J., Jacobson, G., Coleman, J. H., Greenblatt, D. J., Jones, K. J., Levine, P. H., Orsulak, P. J., Peterson, M., Schildkraut, J. J., Uzogara, E., Watkins, D., Carr, D. B., Scott, M. F., Walsh, M. M. & Peltier Saxe, D. R. N. (1985) Lactate-infusion in anxiety research: its evolution and practice. Journal of Clinical Psychiatry, 46, 158165.Google Scholar
Varley, H., Gowenlock, A. H. & Bell, M. (1980) Determination of creatinine in urine. In Practical Clinical Biochemistry, Vol. 1. London: Heinemann.Google Scholar
Weg, M. W., Ruthven, C. R. J., Goodwin, B. L. & Sandler, M. (1975) Specific gas chromatographic measurement of urinary 3, 4-dihydroxyphenylacetic acid. Clinical Chimica Acta, 59, 249251.CrossRefGoogle ScholarPubMed
Zitrin, C. N., Klein, D. F., & Woerner, M. G. (1980) Treatment of agoraphobia with group exposure in vivo and imipramine. Archives of General Psychiatry, 37, 6372.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.